Nurse Practitioner · Honolulu, HI
NPI
1932537586
Since 2013
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1520 Liliha St, Suite 601
Honolulu, HI, 96817
Phone (808) 523-0445
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
248 services
Medicare patients, 2024
56
Average age 72
Drug cost, 2024
$3.2M
8,105 prescriptions
Company payments, 2025
$4,218
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sung Yup Jung was code 99213 (office e&m - established), 94 times for 30 patients. In total Sung Yup Jung billed 248 services in 17 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-10-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 94 | 30 | $56.55 | $5,315 |
| 99214 Office E&M - Established | Office | 88 | 34 | $74.52 | $6,557 |
| 99203 Office E&M - New | Office | 13 | 13 | $66.20 | $861 |
| 99204 Office E&M - New | Office | 12 | 12 | $106.54 | $1,279 |
By year: 2022 $4,866 for 74 services; 2023 $13K for 198 services; 2024 $16K for 248 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sung Yup Jung prescribed most often to Medicare patients was Vascepa (Icosapent Ethyl), with 494 prescriptions and refills. In total Sung Yup Jung wrote 8,105 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vascepa Icosapent Ethyl | 494 | 1,179 | 161 | $425K |
| Atorvastatin Calcium Generic | 415 | 1,228 | 143 | $4,296 |
| Rosuvastatin Calcium Generic | 337 | 990 | 117 | $4,739 |
| Amlodipine Besylate Generic | 334 | 920 | 103 | $2,976 |
| Losartan Potassium Generic | 300 | 841 | 92 | $2,570 |
| Farxiga Dapagliflozin Propanediol | 213 | 475 | 59 | $278K |
| Levothyroxine Sodium Generic | 177 | 454 | 48 | $1,265 |
| Edarbi Azilsartan Medoxomil | 145 | 343 | 37 | $84K |
| Metformin Hcl Generic | 139 | 398 | 41 | $942 |
| Diclofenac Epolamine Generic | 137 | 242 | 39 | $154K |
| Arexvy Rsvpref3 Antigen/As01e/Pf | 126 | 126 | 125 | $35K |
| Metformin Hcl Er Metformin Hcl | 123 | 350 | 49 | $957 |
| Celecoxib Generic | 113 | 228 | 80 | $4,100 |
| Linzess Linaclotide | 110 | 247 | 42 | $135K |
| Prolia Denosumab | 108 | 648 | 71 | $194K |
Brand drugs: 2,603 claims; generic drugs: 5,402 claims; opioid claims: 166.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sung Yup Jung $4,218 ($4,218 in general payments such as food, travel and fees) from 19 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $1,306.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 36 | $1,306 |
| Abbvie Inc. ABBV | 34 | $730 |
| Amgen Inc. AMGN | 28 | $432 |
| Astellas Pharma US Inc 4503.T | 10 | $381 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $240 |
| Genzyme Corporation SNY | 7 | $175 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $169 |
| Pfizer Inc. PFE | 6 | $118 |
| Kowa Pharmaceuticals America, Inc. | 4 | $108 |
| GlaxoSmithKline, LLC. GSK | 4 | $84.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.